EKEkaterina V. Khinovker

Ekaterina V. Khinovker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina V. Khinovker has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidural use of glucocorticosteroids for treating radicular pain: narrative review

    by Dmitrii A. Fedorov, Vladimir V. Khinovker, Viktor A. Koriachkin, Ekaterina V. Khinovker, Alexandr V. Kukharev, Кухарев Александр Васильевич

    This review aimed to examine the history of the epidural use of glucocorticosteroids (GCS), perception of the safety of epidural administration of GCS, and examples of clinical use for the treatment of radiculopathies and radicular pain. The search for publications covered the period from February 2, 2023, to September 1, 2023, in PubMed, Medline, Cochrane Library, and the International Association for the Study of Pain. The search identified 306 studies, of which 243 were excluded because they described the pathophysiology and treatment of chronic pain syndromes other than neuropathic pain and epidural use of GCS. The remaining 63 publications were included in the review. The results of the analysis of the materials and publications revealed that the epidural use of GCS showed high effectiveness both as an independent method of treating radicular pain with neuropathy and as part of complex therapy. In some cases, the epidural use of GCS does not exclude neurosurgical intervention.


  • Open Access

    Diagnostics and treatment of chronic pain in Siberia

    by Vladimir V. Khinovker, Ekaterina V. Khinovker, Viktor A. Koryachkin

    This article is about I Russian scientific and practical conference with the international participation Actual questions of chronic pain management held on May 13-14 in Krasnoyarsk. The conference was organized by the Federal State Budgetary Institution of Healthcare of the Federal Scientific and Practical Center of the Federal Medical and Biological Agency of Russia, the KrasSMU, and the Association of Interventional Pain Treatment. Speakers from nine cities discussed wide and narrow questions of interventional and cancer pain treatment and other pain management directions. Additionally, two regional anesthesia under ultrasound control master classes were conducted. Approximately 360 people participated in the conference, both online and offline.


  • Neuropathic pain treatment with xenon

    by Vladimir V. Khinovker, Olga F. Veselova, Ekaterina V. Khinovker, Viktor A. Koryachkin

    THE AIM: This study aimed to evaluate the effects of xenon on neuropathic pain during parapulmonal injections in the rat model. Xenon is a drug for inhalation anesthesia that is assumed to have an analgesic effect when administered parapulmonary (similar to nitrous oxide and cyclopropane) and can later be used as an alternative analgesic drug in patients with pain syndrome that is not controlled by standard methods. MATERIALS AND METHODS: The experiment used in vivo model of neuropathic pain by Bennet and Xie (1988) on rats with sciatic nerve transection. Additionally, a special scoring was adopted based on known behavioral changes of experimental animals (self-harm of limbs, neatness, activity, and bedding conditions). The control group was subcutaneously administered air daily for 5 days, and the experimental group received medical xenon at 40 ml/kg. The pain was assessed with the subcutaneous introduction of air and xenon in the experimental and control groups. RESULTS: Study results revealed that rats from the experimental group (xenon) showed fewer signs of neuropathic pain syndrome development compared to the control group (air). CONCLUSION: Therefore, parapulmonal injections of xenon showed a high analgesia effect in animal models of chronic neuropathic pain.


  • Open Access

    Safety of parapulmonal application of xenon in the experiment

    by V. V. Khinovker, O. F. Veselova, V. A. Koryachkin, E. V. Khinovker, A. A. Gazenkampf

    Pain syndrome is the most common reason for patients to seek medical care, the importance of which is steadily increasing in the structure of the total incidence. To optimize costs and ensure high-quality treatment of patients with chronic pain syndrome it is necessary to study existing drugs and methods and introduce new ones. Based on theoretical data on the use of inert gases in medicine, a hypothesis was put forward that xenon could have a pronounced analgesic effect when administered subcutaneously. This study is aimed at confirming the safety of xenon in parapulmonary administration to rats.

  • Open Access

    Animal models of chronic pain. In vivo experiments

    by V. V. Khinovker, E. V. Khinovker

    As a result of population aging and increasing of comorbide patients procent, chronic pain nowadays is the one of the most important medical problems and its treatment becoming one of progressive and popular researching topics. First part of acute or chronic pain research is a model that meets the specified criteria. First model of cronic pain sciatic nerve damaging was founded and proven more than 30 years ago. Nowadays there is a lot of in vivo and in vitro models that matched with different pathologies and also mechanisms of chronic nociceptive and neuropathic pain on different levels have been learned. In this article we review the most effective and often used rat models of chronic pain its mechanisms and assessment methods. The information based on the most citated articles for 10 years.